Literature DB >> 1796553

HIV-1 in Ethiopia: phylogenetic divergence from other HIV-1 strains.

S Ayehunie1, B Johansson, M Salminen, P Leinikki, A Sönnerborg, D W Zewdie, S Britton, O Strannegård.   

Abstract

Phylogenetic tree analysis was performed on selected polymerase chain reaction (PCR)-amplified and sequenced regions of the gag and env reading frames of several Ethiopian and Swedish human immunodeficiency virus type 1 (HIV-1) strains. These regions are considered to be conserved parts of the HIV-1 genome and correspond to the p7 of the core (gag) and part of the carboxy terminal of the gp41 protein of env respectively. Comparisons were made with all available HIV-1 sequences. The tree analysis showed that gag sequences from nine and env sequences from four Ethiopian strains all grouped together in separate branches distinct from all other sequenced European, North American, and African HIV-1 isolates. Thus, the Ethiopian strains seem to represent a highly divergent group of HIV-1, which might have developed during a relatively early stage of HIV-1 evolution.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1796553     DOI: 10.1007/BF00271534

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  6 in total

1.  Comparative analysis of the retroviral pol and env protein sequences reveal different evolutionary trees.

Authors:  G Lewe; R M Flügel
Journal:  Virus Genes       Date:  1990-02       Impact factor: 2.332

2.  New subtype of HIV-1 in Ethiopia.

Authors:  S Ayehunie; B Johansson; A Sönnerborg; M Salminen; D W Zewdie; T Fehniger; S Britton; O Strannegård
Journal:  Lancet       Date:  1990-10-13       Impact factor: 79.321

3.  A highly defective HIV-1 strain isolated from a healthy Gabonese individual presenting an atypical western blot.

Authors:  T Huet; M C Dazza; F Brun-Vézinet; G E Roelants; S Wain-Hobson
Journal:  AIDS       Date:  1989-11       Impact factor: 4.177

4.  CLUSTAL: a package for performing multiple sequence alignment on a microcomputer.

Authors:  D G Higgins; P M Sharp
Journal:  Gene       Date:  1988-12-15       Impact factor: 3.688

5.  Detection of HIV-1 DNA and infectious virus in cerebrospinal fluid.

Authors:  A Sönnerborg; B Johansson; O Strannegård
Journal:  AIDS Res Hum Retroviruses       Date:  1991-04       Impact factor: 2.205

6.  Molecular cloning and characterization of a German HIV-1 isolate.

Authors:  U Sauermann; J Schneider; J Mous; U Brunckhorst; I Schedel; K D Jentsch; G Hunsmann
Journal:  AIDS Res Hum Retroviruses       Date:  1990-06       Impact factor: 2.205

  6 in total
  4 in total

1.  Development of a nucleic acid sequence-based amplification assay that uses gag-based molecular beacons to distinguish between human immunodeficiency virus type 1 subtype C and C' infections in Ethiopia.

Authors:  Workenesh Ayele; Georgios Pollakis; Almaz Abebe; Bitew Fisseha; Belete Tegbaru; Girma Tesfaye; Yohannes Mengistu; Dawit Wolday; Bob van Gemen; Jaap Goudsmit; Wendelien Dorigo-Zetsma; Michel P de Baar
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

2.  Sequence analysis of selected regions of the env (V3 loop and gp41) and gag (p7) reading frames of Ethiopian human immunodeficiency virus type 1 strains.

Authors:  S Ayehunie; B Johansson; A Sönnerborg; D W Zewdie; S Britton; O Strannegård
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Raised levels of tumour necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV-1-infected patients from Ethiopia.

Authors:  S Ayehunie; A Sonnerborg; T Yemane-Berhan; D W Zewdie; S Britton; O Strannegard
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

4.  Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT.

Authors:  Hugues Loemba; Bluma Brenner; Michael A Parniak; Shlomo Ma'ayan; Bonnie Spira; Daniela Moisi; Maureen Oliveira; Mervi Detorio; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.